Application | Comment | Organism |
---|---|---|
diagnostics | elevated SIRT5 expression in human breast tumors correlates with poor patient prognosis | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
gene SIRT5 | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | knockdown of SIRT5 in induced onco-Dbl MEFs inhibits cell proliferation. Knockdown of SIRT5 also decreased the volume and number of colonies formed by the induced onco-Dbl MEFs in anchorage-independent growth assays. In breast cancer and lung cancer cell lines, SIRT5 knockdowns again inhibits proliferation and anchorage-independent growth. Expression of RNAi-resistant SIRT5 constructs rescue the proliferative defect caused by the SIRT5-targeted shRNAs | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Homo sapiens | 5739 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
NAD+ + [glutaminase]-N6-succinyl-L-lysine | Homo sapiens | SIRT5 desuccinylates glutaminase residue K164 to block ubiquitination of K158 | nicotinamide + [glutaminase]-L-lysine + 2'-O-succinyl-ADP-ribose | - |
? | |
NAD+ + [protein]-N6-succinyl-L-lysine | Homo sapiens | - |
nicotinamide + [protein]-L-lysine + 2'-O-succinyl-ADP-ribose | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9NXA8 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
breast cancer cell | - |
Homo sapiens | - |
MDA-MB-231 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
NAD+ + [glutaminase]-N6-succinyl-L-lysine | SIRT5 desuccinylates glutaminase residue K164 to block ubiquitination of K158 | Homo sapiens | nicotinamide + [glutaminase]-L-lysine + 2'-O-succinyl-ADP-ribose | - |
? | |
NAD+ + [glutaminase]-N6-succinyl-L-lysine | succinylation of glutaminase residue K164, no activity with K164R-GLS variant | Homo sapiens | nicotinamide + [glutaminase]-L-lysine + 2'-O-succinyl-ADP-ribose | - |
? | |
NAD+ + [protein]-N6-succinyl-L-lysine | - |
Homo sapiens | nicotinamide + [protein]-L-lysine + 2'-O-succinyl-ADP-ribose | - |
? |
Synonyms | Comment | Organism |
---|---|---|
mitochondrial NAD+-dependent lysine deacylase | - |
Homo sapiens |
SIRT5 | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NAD+ | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | SIRT5 is upregulated during cellular transformation and supports proliferation and tumorigenesis | up |
General Information | Comment | Organism |
---|---|---|
malfunction | depletion of SIRT5, a lysine desuccinylase, leads to increased ubiquitination of glutaminase. SIRT5 knockdown acts as a marker for subsequent ubiquitination at residue K158 | Homo sapiens |
physiological function | SIRT5, a mitochondrial NAD+-dependent lysine deacylase, plays a key role in stabilizing glutaminase. In transformed cells, SIRT5 regulates glutamine metabolism by desuccinylating glutaminase and thereby protecting it from ubiquitin-mediated degradation. SIRT5 is upregulated during cellular transformation and supports proliferation and tumorigenesis. SIRT5 is upregulated during oncogenic transformation and stabilizes glutaminase, an enzyme with important functions in cancer-cell metabolic reprogramming. Elevated SIRT5 expression in human breast tumors correlates with poor patient prognosis. Role for SIRT5 in metabolic reprogramming and mammary tumorigenesis. SIRT5 supports proliferation and anchorage-independent growth | Homo sapiens |